BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24380375)

  • 1. Canada's new drug-impaired driving law: the need to consider other approaches.
    Solomon R; Chamberlain E
    Traffic Inj Prev; 2014; 15(7):685-93. PubMed ID: 24380375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The need for drugged driving per se laws: a commentary.
    DuPont RL; Voas RB; Walsh JM; Shea C; Talpins SK; Neil MM
    Traffic Inj Prev; 2012; 13(1):31-42. PubMed ID: 22239141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the Queensland 2007-2012 roadside drug testing program: The prevalence of three illicit drugs.
    Davey J; Armstrong K; Martin P
    Accid Anal Prev; 2014 Apr; 65():11-7. PubMed ID: 24389088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is law enforcement of drug-impaired driving cost-efficient? An explorative study of a methodology for cost-benefit analysis.
    Veisten K; Houwing S; Mathijssen MP; Akhtar J
    Int J Drug Policy; 2013 Mar; 24(2):122-34. PubMed ID: 23127668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Random breath testing: a Canadian perspective.
    Solomon R; Chamberlain E; Abdoullaeva M; Tinholt B
    Traffic Inj Prev; 2011 Apr; 12(2):111-9. PubMed ID: 21469017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs and driving.
    Walsh JM; de Gier JJ; Christopherson AS; Verstraete AG
    Traffic Inj Prev; 2004 Sep; 5(3):241-53. PubMed ID: 15276925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges associated with drunk driving measurement: combining police and self-reported data to estimate an accurate prevalence in Brazil.
    Sousa T; Lunnen JC; Gonçalves V; Schmitz A; Pasa G; Bastos T; Sripad P; Chandran A; Pechansky F
    Injury; 2013 Dec; 44 Suppl 4():S11-6. PubMed ID: 24377772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs and driving: the Finnish perspective.
    Lillsunde P; Gunnar T
    Bull Narc; 2005; 57(1-2):213-29. PubMed ID: 21338023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a more parsimonious approach to drug recognition expert evaluations.
    Porath-Waller AJ; Beirness DJ; Beasley EE
    Traffic Inj Prev; 2009 Dec; 10(6):513-8. PubMed ID: 19916120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roadside survey of alcohol and drug use among Norwegian drivers in 2016-2017: A follow-up of the 2008-2009 survey.
    Furuhaugen H; Jamt REG; Nilsson G; Vindenes V; Gjerde H
    Traffic Inj Prev; 2018; 19(6):555-562. PubMed ID: 29927625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A community driving under the influence (DUI) study of declining arrests.
    Fell JC
    Traffic Inj Prev; 2018; 19(sup2):S147-S151. PubMed ID: 30841810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norwegian roadside survey of alcohol and drug use by drivers (2008-2009).
    Gjerde H; Christophersen AS; Normann PT; Assum T; Oiestad EL; Mørland J
    Traffic Inj Prev; 2013; 14(5):443-52. PubMed ID: 23697895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Victorian legislative framework for the random testing drivers at the roadside for the presence of illicit drugs: an evaluation of the characteristics of drivers detected from 2004 to 2006.
    Boorman M; Owens K
    Traffic Inj Prev; 2009 Mar; 10(1):16-22. PubMed ID: 19214873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting DUI decisions in different legal environments: investigating deterrence with a conjoint experiment.
    Yao J; Johnson MB; Beck KH
    Traffic Inj Prev; 2014; 15(3):213-21. PubMed ID: 24372492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The criminalization of impaired driving in Canada: assessing the deterrent impact of Canada's first per se law.
    Asbridge M; Mann RE; Flam-Zalcman R; Stoduto G
    J Stud Alcohol; 2004 Jul; 65(4):450-9. PubMed ID: 15376819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying Stafford and Warr's reconceptualization of deterrence theory to drug driving: can it predict those likely to offend?
    Watling CN; Palk GR; Freeman JE; Davey JD
    Accid Anal Prev; 2010 Mar; 42(2):452-8. PubMed ID: 20159066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Victorian legislative framework for testing drivers for impairment caused by drugs other than alcohol: an evaluation of the characteristics of drivers detected from 2000 to 2005.
    Boorman M; Papafotiou K
    Traffic Inj Prev; 2007 Sep; 8(3):217-23. PubMed ID: 17710710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A field test of substance use screening devices as part of routine drunk-driving spot detection operating procedures in South Africa.
    Matzopoulos R; Lasarow A; Bowman B
    Accid Anal Prev; 2013 Oct; 59():118-24. PubMed ID: 23770390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral fluid testing for marijuana intoxication: enhancing objectivity for roadside DUI testing.
    Doucette ML; Frattaroli S; Vernick JS
    Inj Prev; 2018 Feb; 24(1):78-80. PubMed ID: 28572268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.